| Ms Sheila A Mueller, CRNA | |
|
1900 John F Kennedy Rd, Dubuque, IA 52002-3800 | |
| (563) 556-8332 | |
| (563) 556-8334 |
| Full Name | Ms Sheila A Mueller |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 1900 John F Kennedy Rd, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962462044 | NPI | - | NPPES |
| 44302200 | Medicaid | WI | |
| 0243345 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | D-106080 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Dubuque Medical Center | Dubuque, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Clinic Pc | 3870491228 | 192 |
News Archive
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).
A Wayne State University researcher believes studying people's ability to find their way around may help explain why loss of mental capacity occurs with age.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new treatment options and improved diagnostic methods for patients suffering from acute promyelocytic leukemia, chronic myeloid leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that are based on a better understanding of the underlying genetic causes of these conditions.
A new technique developed by a University of Central Florida chemist will help physicians more quickly identify the bacterial infections patients have so they can be treated in hours instead of days.
› Verified 8 days ago
| Entity Name | Medical Associates Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457300790 PECOS PAC ID: 3870491228 Enrollment ID: O20031223000311 |
News Archive
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).
A Wayne State University researcher believes studying people's ability to find their way around may help explain why loss of mental capacity occurs with age.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new treatment options and improved diagnostic methods for patients suffering from acute promyelocytic leukemia, chronic myeloid leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that are based on a better understanding of the underlying genetic causes of these conditions.
A new technique developed by a University of Central Florida chemist will help physicians more quickly identify the bacterial infections patients have so they can be treated in hours instead of days.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sheila A Mueller, CRNA 1900 John F Kennedy Rd, Dubuque, IA 52002-3800 Ph: (563) 556-8332 | Ms Sheila A Mueller, CRNA 1900 John F Kennedy Rd, Dubuque, IA 52002-3800 Ph: (563) 556-8332 |
News Archive
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).
A Wayne State University researcher believes studying people's ability to find their way around may help explain why loss of mental capacity occurs with age.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new treatment options and improved diagnostic methods for patients suffering from acute promyelocytic leukemia, chronic myeloid leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that are based on a better understanding of the underlying genetic causes of these conditions.
A new technique developed by a University of Central Florida chemist will help physicians more quickly identify the bacterial infections patients have so they can be treated in hours instead of days.
› Verified 8 days ago
Brett Maag, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St, Suite 300, Dubuque, IA 52001 Phone: 563-557-5991 Fax: 563-589-4078 | |
Matthew J Stader, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-556-8332 Fax: 563-556-8334 | |
Coreyne Lynne Bormann, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 563-582-1881 | |
Phillip Guillien, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 350 N Grandview Ave, Dubuque, IA 52001 Phone: 507-459-2358 | |
Terrence J. Hutchcroft, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi St Suite 300, Dubuque, IA 52001 Phone: 563-557-8500 Fax: 563-589-4050 | |
James W. Wieters, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi St Suite 300, Dubuque, IA 52001 Phone: 563-557-8500 Fax: 563-589-4050 | |
Robert Kyle Matthews, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St, Dubuque, IA 52001 Phone: 563-557-5991 Fax: 563-589-4078 |